HPV Vaccines: A Human Rights Violation?

Human Rights

By K Paul Stoller, MD*, FACHM

Cervical cancer, the second-most common cancer in young women, is particularly prone to be found in the down trodden and in impoverished countries. But this is no endorsement for Human Papilloma Virus (HPV) vaccines. In fact this is about revealing that HPV vaccines were created for only one reason and it wasn’t as a humanitarian effort to minimize cervical cancer. It was created by greed to create income for both a pharmaceutical company and USA governmental agencies National Institutes of Health/Health and Human Services (NIH/HHS) that owned the technology used in the vaccine under the cover of doing something beneficial – a “greater good.”  The HPV vaccine has less value than snake oil – at least snake oil is rich in Omega 3 EFAs, and consuming snake oil won’t harm anyone, but the same cannot be said for the HPV vaccine. The HPV vaccine was never necessary and the true interventions available for those who are concerned about preventing cervical cancer have been suppressed.

Does HPV cause cervical cancer?

While a virus may almost always be a trigger for cancer on a cellular/DNA level – it needs the environment, the internal milieu, to be prepared correctly to allow the wildcat cells to proliferate. Because the public doesn’t know this, it is easy for trusted authorities to impose fear of the virus on the populace just as was done and is still done with polio. It is a tried and true method of disinformation.  In the case of cervical cancer the field upon which it takes hold must be deficient in certain vitamins, and without that deficiency it is very unlikely cervical cancer will take hold.  While it may remain controversial which vitamins, or combinations thereof hold the key, the point is this is about a nutritional issue.

Indole-3-carbinol (I3C) is a phytochemical present in all members of the cruciferous vegetable family including cabbage, broccoli, Brussels sprouts, cauliflower, and kale. In a double-blind, placebo-controlled study,^[1] 30 patients with biopsy-confirmed Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, II-III were randomized to receive placebo or 200 or 400 mg oral I3C daily for 12 weeks. None of the patients in the placebo group had complete regression of CIN. In contrast, four of eight patients in the 200-mg/day group and four of nine in the 400-mg/day group had complete regression of CIN based on 12-week biopsy (400 mg/day, is equivalent to one-third of a head of cabbage.)

Adequate Vitamin D levels need to be present as well, but the point is cervical cancer is far more about malnutrition than an HPV virus. The vitamin D connection is no surprise because adequate vitamin D levels are required to have the immune system deal with viral infections and as most cancer patients are vitamin D deficient, regardless of what cancer they have a vitamin D/cervical cancer connection is a foregone conclusion.

Cigarette smoking, which is known to lower Vitamin D levels, only adds to the risk of cervical cancer. The bottom-line for women to understand is that an HPV infection alone is an insufficient cause of cervical cancer. HPV is but only one risk factor along with cigarette smoking. There is no direct link between HPV and cervical cancer. The vast majority of women will get an HPV infection but they will not get cervical cancer, but in malnourished women cervical cancer becomes a real risk. This is about poverty and nutrition – that is the direct link and the primary cause of cervical cancer.

Do HPV vaccines benefit women’s health?

Those who care about a woman’s risk of cervical cancer would do better to empower women everywhere and provide adequate nourishment, but this isn’t about caring about or for women – this is just about profit nothing less. Now, there has always been a pharmaceutical treatment for HPV infections (except in the USA). ^[2] One study showed that with just a ten day course of therapy with this extremely benign drug (inosine pranobex or Isoprinosine), there was an almost 80% elimination of human papillomavirus (HPV)  16 and 18 in cervical cancer (CIN I-III) and preinvasive cancer of the cervix and of those with recurrent CIN or Ca in situ in the remaining part of the cervix who were infected with (HPV).^[3] This study was published the same year the FDA fast tracked the HPV vaccine.

The vaccines cover HPV 16 & 18, responsible for being the trigger for 70% of cervical cancers, but no one actually knows if the vaccine prevents infection (let alone cancer) – all we know is they increase antibodies to those two viral strains for an unspecified period of time. The vaccines do not cover 16 other HPV strains that can trigger genital cancer (31, 45, 33, 35, 39, 51, 52, 56, 58, 59, 26, 53, 66, 68, 73, 82). We do know getting the vaccine actually increases the risk of getting carcinoma in situ lesions from HPV strains not covered by the vaccine.^[4]

Now this bears repeating, the  FDA apparently knew the vaccine actually increased cervical cancer risk by 40%  in women who had already been exposed to HPV and  used magical thinking  (no scientific evidence) to deal with this problem by recommending approving the vaccine for young girls hoping (I can only assume) they were never exposed – but the evidence is that infants can be exposed during the birth process, and since no testing of HPV serology is done before an HPV vaccine is given nor is it required, the FDA’s decision was irrational until you understand they were doing the bidding of not just Merck but the Health & Human Services Department that owns patents connected to this vaccine and would benefit if the vaccine became widely accepted.

Science or Subterfuge?

In other words, not only was the science behind this vaccine not there, but evidence  showed cancer risk increased significantly. The fact that the NIH/HHS owned patents of the technology used in the vaccine, which was licensed to Merck, had everything to do with how this dangerous vaccine failed upward into approval and a fast-track. This is a total loss of boundaries between corporation and state.

This is now about criminal activity. When the head of the Merck vaccine division^[5] (Julie Gerberding) is the same person in charge of the CDC you have an unholy alliance between corporation and state. The public and the world need to understand that no scientific information coming from the NIH/CDC/FDA/HHS can be trusted nor policies created from same.  The loss of confidence in these agencies is irrecoverable.

Any scientific publication that is authored by anyone coming from or funded by someone either working for the government or a pharmaceutical company can no longer be trusted.

Whether or not the subterfuge behind HPV vaccines constitutes a violation of human rights deserves its own discussion. Nevertheless, several States (USA) will allow 12 year olds to receive this vaccine without parental consent. But a 12 year old cannot enter into a contract anywhere in the USA, so how could they possibly give informed consent for a vaccine?

Again, this aspect of the problem deserves international attention if not international legal intervention, but that is not taking place yet.

KP Stoller, MD* is President of the International Hyperbaric Medical Association, a  lifetime Fellow of the American College of Hyperbaric Medicine, an Adjunct Assistant Clinical Professor (AT Still University SOMA), Chief of Hyperbaric Medicine – Amen Clinics, and was a Fellow of the American Academy of Pediatrics for over two decades until he resigned over their advocacy of mercury preservatives in vaccines. *these above organizations/institutions are for identification purposes only.

References: 

1. Shannon J, Thomas DB, Ray RM, et al. Dietary risk factors for invasive and in-situ cervical carcinomas in Bangkok, Thailand. Cancer Causes Control 2002;13:691-699.
2. Jin L, Qi M, Chen DZ, et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res. 1999 Aug 15;59(16):3991-7.
3. Brot, C. Jorgensen, N. R. Sorensen, O. H. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999 Dec; 53 (12): 920-6.
4. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer. 1998;78:281-285.
5.  Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers. Prev 1995;4:415-428.
6. Chen, P. Hu, P. Xie, D. Qin, Y. Wang, F. Wang, H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010 Jun; 121 (2): 469-77.
7. Friedrich, M. Rafi, L. Mitschele, T. Tilgen, W. Schmidt, W. Reichrath, J. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003; 164239-46.
8. Garland, C. F. Gorham, E. D. Mohr, S. B. Garland, F. C. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009 Jul; 19 (7): 468-83.
9. Grant, W. B. Does solar ultraviolet irradiation affect cancer mortality rates in China?. Asian Pac J Cancer Prev. 2007 Apr-Jun; 8 (2): 236-42.
10. Grant, W. B. A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007 Mar; 103 (3-5): 668-74.
11. Grant, W. B. Benefits of vitamin D in reducing the risk of cancer: Time to include vitamin D in cancer treatment?. J Soc Integr Oncol. 2010 Summer; 8 (3): 81-8.
12. Grant, W. B. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B. 2010 May 12;
13. Grant, W. B. Cancer risk ecological study in Rhineland-Palatinate, Germany, provides strong support for the ultraviolet B-vitamin D-cancer hypothesis. J Occup Med Toxicol. 2010 19 July 2010; 19 July 2010
14. Grant, W. B. Garland, C. F. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006 Jul-Aug; 26 (4A): 2687-99.
15. Hosono, S. Matsuo, K. Kajiyama, H. Hirose, K. Suzuki, T. Kawase, T. Kidokoro, K. Nakanishi, T. Hamajima, N. Kikkawa, F. Tajima, K. Tanaka, H. Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. Eur J Clin Nutr. 2010 Apr; 64 (4): 400-9.
16. Hrushesky, W. J. Sothern, R. B. Rietveld, W. J. Du Quiton, J. Boon, M. E. Season, sun, sex, and cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14 (8): 1940-7.
17. Hrushesky, W. J. Sothern, R. B. Rietveld, W. J. Du-Quiton, J. Boon, M. E. Sun exposure, sexual behavior and uterine cervical human papilloma virus. Int J Biometeorol. 2006 Jan; 50 (3): 167-73.
18. Ingraham, B. A. Bragdon, B. Nohe, A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008 Jan; 24 (1): 139-49.
19. Lappe, J. M. Travers-Gustafson, D. Davies, K. M. Recker, R. R. Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun; 85 (6): 1586-91.
20. Oplander, C. Volkmar, C. M. Paunel-Gorgulu, A. van Faassen, E. E. Heiss, C. Kelm, M. Halmer, D. Murtz, M. Pallua, N. Suschek, C. V. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res. 2009 Nov 6; 105 (10): 1031-40.
21. Reinhold, U. Schmitz, B. Kurbacher, C. Nagel, W. Schmidt, M. Malaisse, W. J. Circulating 25-hydroxyvitamin D concentration in German cancer patients. Oncology reports. 2008 Dec; 20 (6): 1539-43.
22. Seidler, A. Hammer, G. P. Husmann, G. Konig, J. Krtschil, A. Schmidtmann, I. Blettner, M. Cancer risk among residents of Rhineland-Palatinate winegrowing communities: a cancer-registry based ecological study. J Occup Med Toxicol. 2008; 312.
23. Shaykhiev, R. Otaki, F. Bonsu, P. Dang, D. T. Teater, M. Strulovici-Barel, Y. Salit, J. Harvey, B. G. Crystal, R. G. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2010 Sep 6;
24. Tsai HT, Tsai YM, Yang SF, Wu KY, Chuang HY, Wu TN, Ho CK, Lin CC, Kuo YS, Wu MT. Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm–a community-based case-control study. Gynecol Oncol. 2007 Apr; 105 (1): 181-8.
25. Villiotou, V. Deliconstantinos, G. Nitric oxide, peroxynitrite and nitroso-compounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. Anticancer Res. 1995 May-Jun; 15 (3): 931-42.
26. Wei, L. Gravitt, P. E. Song, H. Maldonado, A. M. Ozbun, M. A. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res. 2009 Jun 1; 69 (11): 4878-84.